• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

    1.320 +0.110 (+9.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,932,077
    Open 1.465
    Bid (Size) 1.320 (100)
    Ask (Size) 1.360 (500)
    Prev. Close 1.210
    Today's Range 1.260 - 1.510
    52wk Range 1.140 - 4.079
    Shares Outstanding 174,537,458
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Akebia (AKBA) Q4 2025 Earnings Call Transcript ↗
    Akebia (AKBA) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗
    The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027. 
    Via Stocktwits

    Performance

    YTD
    -14.8%
    -14.8%
    1 Month
    -7.7%
    -7.7%
    3 Month
    -17.0%
    -17.0%
    6 Month
    -56.1%
    -56.1%
    1 Year
    -27.5%
    -27.5%

    More News

    Read More
    Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction ↗
    Via Chartmill
    News headline image
    Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    An Overview of Akebia Therapeutics's Earnings ↗
    Via Benzinga
    Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
    Via Benzinga
    News headline image
    FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Earnings Preview For Akebia Therapeutics ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
    Via Benzinga
    News headline image
    Insights Ahead: Akebia Therapeutics's Quarterly Earnings ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Akebia (AKBA) Q2 Revenue Jumps 43% ↗
    Via The Motley Fool
    News headline image
    9 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    News headline image
    Top movers in Thursday's session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Akebia Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?
    Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?
    The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market
    What is the current price of Akebia Therapeutics, Inc. - Common Stock?
    The current price of Akebia Therapeutics, Inc. - Common Stock is 1.320
    When was Akebia Therapeutics, Inc. - Common Stock last traded?
    The last trade of Akebia Therapeutics, Inc. - Common Stock was at 02/26/26 04:00 PM ET
    What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?
    The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 230.39M
    How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?
    Akebia Therapeutics, Inc. - Common Stock has 230M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.